Exhibit 99.1
PRESS RELEASE
Contact:
For Release May 15, 2008
J. Scott Kamsler Sr. Vice President and CFO 510-668-7110 |
Exar Corporation Reports Fiscal 2008 Fourth Quarter and Year End Results
Fremont, California, May 15, 2008 – Exar Corporation (NasdaqGM: EXAR), today reported financial results for its fiscal 2008 fourth quarter and year-ended, March 30, 2008.
Revenue
Net sales for the fourth quarter of fiscal 2008 were $28.3 million compared to net sales of $25.2 million for the prior quarter and to net sales of $15.7 million for the same period last year. Net sales for fiscal year 2008 were $89.7 million compared to net sales of $68.5 million for fiscal year 2007. Fiscal 2008 fourth quarter net sales exclude approximately $2.5 million of shipments (1) from Sipex distributor inventories held prior to the acquisition of Sipex and (2) to the Company's two primary distributors as a result of the change in revenue recognition to the sell-through method.
CEO Comment
“I welcome this opportunity and I am firmly committed to increasing revenue and achieving operational profitability,” said Pete Rodriguez, the Company’s president and chief executive officer. “We continue to be operationally cash flow positive, have strong customer engagements and provide proven technologies to capitalize on unique market opportunities. I am encouraged by our team's ongoing measures to continue to improve operations and I am optimistic about our prospects going forward.”
Gross Margin
On a GAAP basis, the gross margin for the fourth quarter of fiscal 2008 was 37.9% as compared to 30.0% for the prior quarter. On a non-GAAP basis, the gross margin for the fourth quarter of fiscal 2008 was 45.3% as compared to 47.3% for the prior quarter. Both the GAAP and Non-GAAP gross margins for the fourth quarter are net of costs of approximately two percent as a result of a product issue which is being addressed.
Impairment Charge
The results for the fiscal 2008 fourth quarter and year include a non-cash charge of $165.2 million, for the impairment of goodwill and other intangible assets related to the acquisition of
PAGE 1OF 5
Sipex. This charge resulted from the evaluation of the Company’s carrying value of goodwill and other intangible assets which was required under FASB Statements No. 142 and No. 144 as the Company’s market capitalization was below its net book value for an extended period. This impairment charge does not affect the Company’s business, its operations or its cash position.
Net Income
The GAAP net loss for the fiscal quarter ended March 30, 2008 was $172.4 million, or $3.77 loss per share, which included the $165.2 million impairment charge, compared to a net loss of $11.7 million, or $0.24 loss per share, in the previous quarter and net income of $1.3 million, or $0.03 diluted earnings per share, for the fiscal quarter ended March 31, 2007. The non-GAAP net loss for the fiscal quarter ended March 30, 2008 was $1.7 million, or $0.04 loss per share, as compared to the non-GAAP net loss of $1.8 million, or $0.04 loss per share, in the previous quarter, and non-GAAP net income of $2.7 million, or $0.07 diluted earnings per share, in the fourth quarter of fiscal 2007.
The GAAP net loss for fiscal year 2008 was $195.9 million, or $4.55 loss per share, as compared to net income of $8.0 million, or $0.22 diluted earnings per share, for the previous fiscal year. The non-GAAP net income for fiscal 2008 was $8.5 million, or $0.19 diluted earnings per share, as compared to non-GAAP net income of $13.5 million, or $0.37 diluted earnings per share, for the previous fiscal year.
Cash Flow
During the fourth quarter of fiscal 2008, the Company’s cash, cash equivalents and short-term marketable securities decreased by $34.5 million to approximately $269 million primarily as a result of $35.0 million used to repurchase approximately 4.5 million shares of the Company’s common stock at an average price of $7.77 per share. The Company generated cash from operations of $3.4 million in the March 2008 quarter and $13.8 million in fiscal year 2008.
Current Business Outlook
For the first quarter of fiscal 2009 ending June 29, 2008, the Company projects that net sales will increase to between $29.0 million and $31.5 million.The gross margin is expected to be between 44% and 46% on a GAAP basis and between 47% and 49% on a non-GAAP basis. Operating expenses are expected to be between $19.2 million and $19.7 million on a GAAP basis and between $17.2 million and $17.7 million on a non-GAAP basis.
The Company’s statements about its future financial performance, product introductions or operating plans are based on current information and expectations and the Company undertakes no duty to update such statements. These statements are forward-looking and actual results could differ materially due to various risks and uncertainties, some of which are described herein.
PAGE 2OF 5
Generally Accepted Accounting Principles
The Company reports its financial results in accordance with GAAP. Additionally, the Company from time to time supplements reported GAAP financials with non-GAAP measures which are included in related press releases and reports furnished to the SEC, copies of which are available at the Company’s website: http://www.exar.com or the SEC’s website at: http://www.sec.gov. For the period presented, we are disclosing non-GAAP gross margins, non-GAAP research and development expenses, non-GAAP selling, general and administrative expenses, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP net income (loss), and non-GAAP diluted earnings (loss) per share, which are adjusted to exclude from our GAAP results all stock-based compensation expense, amortization of acquired intangible assets, fair value adjustment of acquired inventories, merger-related costs, in-process research and development, separation costs of executive officers goodwill and other intangible asset impairment, other than temporary loss on long-term investments, income tax effects, charge to establish deferred tax asset valuation allowance and an income tax benefit from the closure of federal tax audit. These non-GAAP measures are presented in part to enhance the understanding of the Company’s historical financial performance and comparability between reporting periods. The Company believes the non-GAAP presentation, when shown in conjunction with the corresponding GAAP measures, provide relevant and useful information to analysts, investors, management and other interested parties following the semiconductor industry. For its internal purposes, the Company uses the foregoing non-GAAP measures to evaluate performance across reporting periods, determine certain employee benefits as well as plan for and forecast the Company’s future periods. These non-GAAP measures are not in accordance with, or an alternative for measures prepared in accordance with GAAP, and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP. These measures should only be used to evaluate the Company’s results of operations in conjunction with the corresponding GAAP measures.
Results Conference Call
The Company invites investors, financial analysts, and the general public to listen to its conference call discussing the Company’s financial results for the fourth quarter of fiscal 2008, today, Thursday, May 15, 2008 at 1:30 p.m. PDT/4:30 p.m. EDT. To access the conference call, please dial (888) 428-4479 by 1:20 p.m. PDT/4:20 p.m. EDT and use conference ID number 920564. In addition, a live webcast will also be available. To access the webcast, please go to the Company's Investor Relations Homepage at: http://www.exar.com. A replay of the call will be available starting at 5:00 p.m. PDT/8:00 p.m. EDT this afternoon until 11:59 p.m. PDT on May 22, 2008/2:59 a.m. EDT on May 23, 2008. To access the replay, please dial (800) 475-6701 and use conference ID number 920564.
PAGE 3OF 5
Product Line Highlights
Power Management
Exar Launches 1.5 MHz, 600mA Step-Down Inductive Converter — Supports Systems with Universal Serial Bus (USB) Interface
http://www.exar.com/Common/Content/News.aspx?id=3630
Exar Offers Light Emitting Diode (LED) Driver with Inductive Boost Capabilities – Ideal for Space Constrained Backlighting Applications
http://www.exar.com/Common/Content/News.aspx?id=3592
Exar’s Light Emitting Diode (LED) Driver Delivers Reduced Board Space Requirements Critical in the Design of Handheld Electronics
http://www.exar.com/Common/Content/News.aspx?id=3568
Exar Announces New PowerBlox™ Solution — 29V Input, 4A Peak Output Current Buck Regulator in 8-Lead Surface Mount Power Package
http://www.exar.com/Common/Content/News.aspx?id=3538
Exar Continues to Provide New Solutions for Driving High Power Light Emitting Diodes (LEDs)
http://www.exar.com/Common/Content/News.aspx?id=3504
Exar Releases First in a Family of Boost Controllers Supporting Light Emitting Diode (LED) Lighting and General DC/DC Conversion
http://www.exar.com/Common/Content/News.aspx?id=3288
Communications
Exar Extends Market Proven EXstor™ Storage Product Family with Two eSATA Compliant Products: 2:1 eSATA Port Selector and 2:2 eSATA Two Port Selector/Multiplier Combo
http://www.exar.com/Common/Content/News.aspx?id=3578
Interface
Exar Adds 5V RS-485/RS-422 Half-Duplex Transceiver —
http://www.exar.com/Common/Content/News.aspx?id=3278
Safe Harbor Statement
The Company’s statements about its future financial performance, anticipated results in connection with the acquisition of Sipex Corporation, changes in gross margins, revenues and operating expenses, uncertain timing of expense reductions or synergies associated with corporate restructuring, internal initiatives, distribution and OEM trends, supply chain issues
PAGE 4OF 5
among others, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include global economic, industry and market conditions, such as customer and distributor relationships; limited visibility associated with customer demand for the Company’s products; the possible loss of, or decrease in orders from, an important customer; adjustments in interest rates and cash balances; vendor capacity or throughput constraints; possible disruption in commercial activities as a consequence of terrorist activity, natural disasters, armed conflict or health issues; successful development, market acceptance and demand for the Company’s products, including those for which the Company has achieved design wins; competitive factors, such as pricing or competing solutions; customer ordering patterns; accounting considerations related to option expensing or merger related issues; the level of inventories maintained at the Company’s OEMs and distributors; and the Company’s successful execution of internal performance plans, as well as the other risks detailed from time to time in the Company’s SEC reports, including the Annual Report on Form 10-K for the year ended March 31, 2007 and quarterly reports on Form 10-Q for the quarters ended June 30, 2007, September 30, 2007 and December 30, 2007, as well as those risks set forth in Sipex Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006 and its quarterly report on Form 10-Q for the quarter ended June 30, 2007.
About Exar
Exar Corporation is Powering Connectivity by delivering highly differentiated silicon solutions empowering products to connect. With distinctive knowledge in analog and digital technologies, Exar enables a wide array of applications such as portable devices, home media gateways, communications systems, and industrial automation equipment. Exar has locations worldwide providing real-time system-level support to drive rapid product innovation. For more information about Exar visit: http://www.exar.com.
# # #
PAGE 5OF 5
EXAR CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
| MARCH 30, 2008 | MARCH 31, 2007 | |||||||
| ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 122,016 | $ | 119,809 | ||||
Short-term marketable securities | 146,844 | 236,270 | ||||||
Accounts receivable (net of allowances of $739 and $322) | 9,943 | 4,028 | ||||||
Accounts receivable, related party (net of allowances of $1,063 and $816) | 3,712 | 338 | ||||||
Inventories | 14,201 | 4,779 | ||||||
Interest receivable and prepaid expenses | 3,889 | 5,262 | ||||||
Deferred income taxes, net | 507 | 809 | ||||||
Total current assets | 301,112 | 371,295 | ||||||
Property, plant and equipment, net | 46,130 | 25,404 | ||||||
Goodwill | 47,626 | 5,190 | ||||||
Intangible assets, net | 26,019 | 5,451 | ||||||
Other non-current assets | 697 | 562 | ||||||
Long-term investments | 2,636 | 2,670 | ||||||
Deferred income taxes, net | — | 10,602 | ||||||
Total assets | $ | 424,220 | $ | 421,174 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts Payable | $ | 8,801 | $ | 2,139 | ||||
Accrued compensation and related benefits | 5,744 | 3,418 | ||||||
Deferred income and allowances on sales to distributors | 3,253 | — | ||||||
Deferred income and allowances on sales to distributors, related party | 9,118 | — | ||||||
Other accrued expenses | 8,136 | 3,150 | ||||||
Income tax payable | — | 5,520 | ||||||
Total current liabilities | 35,052 | 14,227 | ||||||
Long-term lease financing obligations | 16,379 | — | ||||||
Other non-current obligations | 1,712 | 191 | ||||||
Total liabilities | 53,143 | 14,418 | ||||||
Total stockholders’ equity | ||||||||
Preferred stock, $.0001 par value; 2,250,000 shares authorized; no shares outstanding | — | — | ||||||
Common stock, $.0001 par value; 100,000,000 shares authorized; 43,928,762 and 36,154,815 shares issued and outstanding at March 30, 2008 and March 31, 2007, respectively (net of treasury shares) | 4 | 4 | ||||||
Additional paid-in capital | 702,217 | 451,084 | ||||||
Accumulated other comprehensive income | 1,873 | 76 | ||||||
Treasury stock at cost, 18,288,021 and 9,015,257 shares at March 30, 2008 and March 31, 2007, respectively | (235,537 | ) | (142,572 | ) | ||||
Retained Earnings | (97,480 | ) | 98,164 | |||||
Total stockholders’ equity | 371,077 | 406,756 | ||||||
Total liabilities and stockholders’ equity | $ | 424,220 | $ | 421,174 | ||||
EXAR CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
| THREE MONTHS ENDED | TWELVE MONTHS ENDED | |||||||||||||||||||
| MARCH 30, 2008 | DECEMBER 30, 2007 | MARCH 31, 2007 | MARCH 30, 2008 | MARCH 31, 2007 | ||||||||||||||||
Net sales | $ | 18,356 | $ | 20,691 | $ | 12,233 | $ | 67,925 | $ | 54,580 | ||||||||||
Net sales, related party | 9,906 | 4,516 | 3,427 | 21,818 | 13,922 | |||||||||||||||
Total net sales | 28,262 | 25,207 | 15,660 | 89,743 | 68,502 | |||||||||||||||
Cost of sales: | ||||||||||||||||||||
Cost of sales | 10,798 | 12,422 | 4,045 | 33,773 | 17,041 | |||||||||||||||
Cost of sales, related party | 5,244 | 2,679 | 1,045 | 10,406 | 3,967 | |||||||||||||||
Amortization of purchased intangible assets | 1,515 | 2,539 | 240 | 5,452 | 960 | |||||||||||||||
Total cost of sales | 17,557 | 17,640 | 5,330 | 49,631 | 21,968 | |||||||||||||||
Gross profit | 10,705 | 7,567 | 10,330 | 40,112 | 46,534 | |||||||||||||||
Operating expenses: | ||||||||||||||||||||
Research and development | 8,259 | 8,890 | 6,325 | 30,660 | 25,838 | |||||||||||||||
Selling, general and administrative | 11,793 | 12,071 | 6,834 | 37,899 | 24,925 | |||||||||||||||
Goodwill and other intangible asset impairment | 165,191 | — | — | 165,191 | — | |||||||||||||||
Acquired in-process research and development | — | — | — | 8,800 | — | |||||||||||||||
Total operating expenses | 185,243 | 20,961 | 13,159 | 242,550 | 50,763 | |||||||||||||||
Loss from operations | (174,538 | ) | (13,394 | ) | (2,829 | ) | (202,438 | ) | (4,229 | ) | ||||||||||
Other income, net: | ||||||||||||||||||||
Interest income and other, net | 2,922 | 3,377 | 4,294 | 15,266 | 16,526 | |||||||||||||||
Other than temporary loss on long-term investments | (142 | ) | — | — | (591 | ) | (957 | ) | ||||||||||||
Total interest and other income, net | 2,780 | 3,377 | 4,294 | 14,675 | 15,569 | |||||||||||||||
Income (loss) before income taxes | (171,758 | ) | (10,017 | ) | 1,465 | (187,763 | ) | 11,340 | ||||||||||||
Provision for income taxes | 640 | 1,665 | 210 | 8,116 | 3,316 | |||||||||||||||
Net income (loss) | $ | (172,398 | ) | $ | (11,682 | ) | $ | 1,255 | $ | (195,879 | ) | $ | 8,024 | |||||||
Earnings (loss) per share: | ||||||||||||||||||||
Basic earnings (loss) per share | $ | (3.77 | ) | $ | (0.24 | ) | $ | 0.03 | $ | (4.55 | ) | $ | 0.22 | |||||||
Diluted earnings (loss) per share | $ | (3.77 | ) | $ | (0.24 | ) | $ | 0.03 | $ | (4.55 | ) | $ | 0.22 | |||||||
Shares used in the computation of earnings (loss) per share: | ||||||||||||||||||||
Basic | 45,712 | 49,301 | 36,254 | 43,090 | 36,255 | |||||||||||||||
Diluted | 45,712 | 49,301 | 36,369 | 43,090 | 36,480 | |||||||||||||||
EXAR CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(In thousands, except per share amounts)
(Unaudited)
| THREE MONTHS ENDED | TWELVE MONTHS ENDED | |||||||||||||||||||
| MARCH 30, 2008 | DECEMBER 30, 2007 | MARCH 31, 2007 | MARCH 30, 2008 | MARCH 31, 2007 | ||||||||||||||||
GAAP gross margin | 37.9 | % | 30.0 | % | 66.0 | % | 44.7 | % | 67.9 | % | ||||||||||
Stock-based compensation | 0.5 | % | 1.4 | % | 0.1 | % | 0.7 | % | 0.1 | % | ||||||||||
Amortization of acquired intangible assets | 5.4 | % | 10.1 | % | 1.5 | % | 6.1 | % | 1.4 | % | ||||||||||
Fair value adjustment of acquired inventories | 1.5 | % | 5.8 | % | — | 2.5 | % | — | ||||||||||||
Merger-related costs | 0.1 | % | — | — | 0.1 | % | — | |||||||||||||
Non-GAAP gross margin | 45.3 | % | 47.3 | % | 67.6 | % | 54.0 | % | 69.5 | % | ||||||||||
GAAP research and development expenses | $ | 8,259 | $ | 8,890 | $ | 6,325 | $ | 30,660 | $ | 25,838 | ||||||||||
Stock-based compensation | 270 | 389 | 218 | 1,207 | 1,181 | |||||||||||||||
Merger-related costs | 131 | 9 | — | 393 | — | |||||||||||||||
Non-GAAP research and development expenses | $ | 7,858 | $ | 8,492 | $ | 6,107 | $ | 29,060 | $ | 24,657 | ||||||||||
GAAP selling, general and administrative expenses | $ | 11,793 | $ | 12,071 | $ | 6,834 | $ | 37,899 | $ | 24,925 | ||||||||||
Stock-based compensation | 884 | 1,035 | 831 | 3,366 | 3,077 | |||||||||||||||
Amortization of acquired intangible assets | 266 | 474 | — | 936 | — | |||||||||||||||
Merger-related costs | 717 | 509 | — | 1,992 | — | |||||||||||||||
Separation costs of executive officers | — | 465 | 985 | 465 | 1,649 | |||||||||||||||
Non-GAAP selling, general and administrative expenses | $ | 9,926 | $ | 9,588 | $ | 5,018 | $ | 31,140 | $ | 20,199 | ||||||||||
GAAP operating expenses | $ | 185,243 | $ | 20,961 | $ | 13,159 | $ | 242,550 | $ | 50,763 | ||||||||||
Stock-based compensation | 1,154 | 1,424 | 1,049 | 4,573 | 4,258 | |||||||||||||||
Amortization of acquired intangible assets | 266 | 474 | — | 936 | — | |||||||||||||||
In-process research and development | — | — | — | 8,800 | — | |||||||||||||||
Merger-related costs | 848 | 518 | — | 2,385 | — | |||||||||||||||
Separation costs of executive officers | — | 465 | 985 | 465 | 1,649 | |||||||||||||||
Goodwill and other intangible asset impairment | 165,191 | — | — | 165,191 | — | |||||||||||||||
Non-GAAP operating expenses | $ | 17,784 | $ | 18,080 | $ | 11,125 | $ | 60,200 | $ | 44,856 | ||||||||||
GAAP operating income (loss) | $ | (174,538 | ) | $ | (13,394 | ) | $ | (2,829 | ) | $ | (202,438 | ) | $ | (4,229 | ) | |||||
Stock-based compensation | 1,282 | 1,785 | 1,063 | 5,196 | 4,349 | |||||||||||||||
Amortization of acquired intangible assets | 1,781 | 3,013 | 240 | 6,388 | 960 | |||||||||||||||
Fair value adjustment of acquired inventories | 432 | 1,458 | — | 2,231 | — | |||||||||||||||
In-process research and development | — | — | — | 8,800 | — | |||||||||||||||
Merger-related costs | 884 | 518 | — | 2,437 | — | |||||||||||||||
Separation costs of executive officers | — | 465 | 985 | 465 | 1,649 | |||||||||||||||
Goodwill and other intangible asset impairment | 165,191 | — | — | 165,191 | — | |||||||||||||||
Non-GAAP operating income (loss) | $ | (4,968 | ) | $ | (6,155 | ) | $ | (541 | ) | $ | (11,730 | ) | $ | 2,729 | ||||||
GAAP net income (loss) | $ | (172,398 | ) | $ | (11,682 | ) | $ | 1,255 | $ | (195,879 | ) | $ | 8,024 | |||||||
Stock-based compensation | 1,282 | 1,785 | 1,063 | 5,196 | 4,349 | |||||||||||||||
Amortization of acquired intangible assets | 1,781 | 3,013 | 240 | 6,388 | 960 | |||||||||||||||
Fair value adjustment of acquired inventories | 432 | 1,458 | — | 2,231 | — | |||||||||||||||
In-process research and development | — | — | — | 8,800 | — | |||||||||||||||
Merger-related costs | 884 | 518 | — | 2,437 | — | |||||||||||||||
Separation costs of executive officers | — | 465 | 985 | 465 | 1,649 | |||||||||||||||
Goodwill and other intangible asset impairment | 165,191 | — | — | 165,191 | — | |||||||||||||||
Other than temporary loss on long-term investments | 142 | — | — | 591 | 957 | |||||||||||||||
Income tax effects | 1,035 | 2,691 | (859 | ) | 6,694 | (2,394 | ) | |||||||||||||
Charge to establish deferred tax asset valuation allowance | — | — | — | 8,323 | — | |||||||||||||||
Income tax benefit from the closure of federal tax audit | — | — | — | (1,933 | ) | — | ||||||||||||||
Non-GAAP net income (loss) | $ | (1,651 | ) | $ | (1,752 | ) | $ | 2,684 | $ | 8,504 | $ | 13,545 | ||||||||
GAAP diluted earnings (loss) per share | $ | (3.77 | ) | $ | (0.24 | ) | $ | 0.03 | $ | (4.55 | ) | $ | 0.22 | |||||||
Stock-based compensation | 0.03 | 0.04 | 0.03 | 0.12 | 0.12 | |||||||||||||||
Amortization of acquired intangible assets | 0.04 | 0.06 | 0.01 | 0.16 | 0.03 | |||||||||||||||
Fair value adjustment of acquired inventories | 0.01 | 0.03 | — | 0.05 | — | |||||||||||||||
In-process research and development | — | — | — | 0.21 | — | |||||||||||||||
Merger-related costs | 0.02 | 0.01 | — | 0.06 | — | |||||||||||||||
Separation costs of executive officers | — | 0.01 | 0.03 | 0.01 | 0.05 | |||||||||||||||
Goodwill and other intangible asset impairment | 3.61 | — | — | 3.80 | — | |||||||||||||||
Other than temporary loss on long-term investments | — | — | — | 0.01 | 0.03 | |||||||||||||||
Income tax effects | 0.02 | 0.05 | (0.02 | ) | 0.16 | (0.07 | ) | |||||||||||||
Charge to establish deferred tax asset valuation allowance | — | — | — | 0.20 | — | |||||||||||||||
Income tax benefit from the closure of federal tax audit | — | — | — | (0.04 | ) | — | ||||||||||||||
Non-GAAP diluted earnings (loss) per share | $ | (0.04 | ) | $ | (0.04 | ) | $ | 0.07 | $ | 0.19 | $ | 0.37 | ||||||||
Shares used in diluted earnings (loss) per share — GAAP | 45,712 | 49,301 | 36,369 | 43,090 | 36,480 | |||||||||||||||
The effect of dilutive potential common shares due to reporting Non-GAAP net income | — | — | 95 | 540 | 137 | |||||||||||||||
The effect of removing stock-based compensation expense under SFAS 123R for Non-GAAP presentation purpose | — | — | (115 | ) | — | (225 | ) | |||||||||||||
Shares used in diluted earnings per (loss) share — Non-GAAP | 45,712 | 49,301 | 36,349 | 43,630 | 36,392 | |||||||||||||||
Note: certain amounts may not total due to rounding